The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.
Open accessAbstract
The lymphocyte-high endothelial venule (HEV) cell interaction is an essential element of the immune system, as it controls lymphocyte recirculation between blood and lymphoid organs in the body. This interaction involves an 85-95-kD class of lymphocyte surface glycoprotein(s), CD44. A subset of lymphocyte CD44 molecules is modified by covalent linkage to chondroitin sulfate (Jalkanen, S., M. Jalkanen, R. Bargatze, M. Tammi, and E. C. Butcher. 1988. J. Immunol. 141:1615-1623). In this work, we show that removal of chondroitin sulfate by chondroitinase treatment of lymphocytes or incubation of HEV with chondroitin sulfate does not significantly inhibit lymphocyte binding to HEV, suggesting that chondroitin sulfate is not involved in endothelial cell recognition of lymphocytes. Affinity-purified CD44 antigen was, on the other hand, observed to bind native Type I collagen fibrils, laminin, and fibronectin, but not gelatin. Binding to fibronectin was studied more closely, and it was found to be mediated through the chondroitin sulfate-containing form of the molecule. The binding site on fibronectin was the COOH-terminal heparin binding domain, because (a) the COOH-terminal heparin-binding fragment of fibronectin-bound isolated CD44 antigen; (b) chondroitin sulfate inhibited this binding; and (c) finally, the ectodomain of another cell surface proteoglycan, syndecan, which is known to bind the COOH-terminal heparin binding domain of fibronectin (Saunders, S., and M. Bernfield. 1988. J. Cell Biol. 106: 423-430), inhibited binding of CD44 both to intact fibronectin and to its heparin binding domain. Moreover, inhibition studies showed that binding of a lymphoblastoid cell line, KCA, to heparin binding peptides from COOH-terminal heparin binding fragment of fibronectin was mediated via CD44. These findings suggest that recirculating lymphocytes use the CD44 class of molecules not only for binding to HEV at the site of lymphocyte entry to lymphoid organs as reported earlier but also within the lymphatic tissue where CD44, especially the subset modified by chondroitin sulfate, is used for interaction with extracellular matrix molecules such as fibronectin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD44 is the principal cell surface receptor for hyaluronate
Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., & Seed, B. (1990) · Cell · doi:10.1016/0092-8674(90)90694-a · Cited by 2,438
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
Pytela, R., Pierschbacher, M. D., & Ruoslahti, E. (1985) · Cell · doi:10.1016/0092-8674(85)90322-8 · Cited by 1,101
Wayner, E. A., Garcia-Pardo, A., Humphries, M. J., McDonald, J. A., & Carter, W. G. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.3.1321 · Cited by 783
Structure and Biology of Proteoglycans
Ruoslahti, E. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.001305 · Cited by 713
Proteoglycans in Cell Regulation
Ruoslahti, E. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80001-1 · Cited by 679
Stamenkovic, I., Amiot, M., Pesando, J. M., & Seed, B. (1989) · Cell · doi:10.1016/0092-8674(89)90638-7 · Cited by 672
Stamper, H. B., & Woodruff, J. J. (1976) · The Journal of experimental medicine · doi:10.1084/jem.144.3.828 · Cited by 670
Miyake, K., Underhill, C. B., Lesley, J., & Kincade, P. W. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.1.69 · Cited by 618
Guan, J.-L., & Hynes, R. O. (1990) · Cell · doi:10.1016/0092-8674(90)90715-q · Cited by 601
Cited by
The sweet and sour of cancer: glycans as novel therapeutic targets
Fuster, M. M., & Esko, J. D. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1649 · Cited by 1,383
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Zöller, M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3023 · Cited by 1,112
CD44 and Its Interaction with Extracellular Matrix
Lesley, J., Hyman, R., & Kincade, P. W. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60537-4 · Cited by 1,059
CD44: Structure, Function and Association with the Malignant Process
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60101-3 · Cited by 1,016
Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U., & Bell, J. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12160 · Cited by 1,015
Extracellular matrix and its therapeutic potential for cancer treatment
Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962
Cancer metastases: challenges and opportunities
Guan, X. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.07.005 · Cited by 952
Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers
Rempe, R. G., Hartz, A. M., & Bauer, B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16655551 · Cited by 721
Yu, Q., & Stamenkovic, I. (1999) · Genes & Development · doi:10.1101/gad.13.1.35 · Cited by 713
Goodison, S., Urquidi, V, & Tarin, D. (1999) · Molecular Pathology · doi:10.1136/mp.52.4.189 · Cited by 679
Underhill, C. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.2.293 · Cited by 609
Naor, D., Nedvetzki, S., Golan, I., Melnik, L., & Faitelson, Y. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795574 · Cited by 557
Morrison, H., Sherman, L. S., Legg, J., Banine, F., Isacke, C., Haipek, C. A., Gutmann, D. H., Ponta, H., & Herrlich, P. (2001) · Genes & Development · doi:10.1101/gad.189601 · Cited by 536
Damsky, C. H., & Werb, Z. (1992) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(92)90100-q · Cited by 518
A crucial role for CD44 in inflammation
Puré, E., & Cuff, C. A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)01963-3 · Cited by 472
HA receptors: Regulators of signalling to the cytoskeleton
Entwistle, J., Hall, C. L., & Turley, E. A. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960616)61:4<569::aid-jcb10>3.0.co;2-b · Cited by 472
The collagen family members as cell adhesion proteins
Heino, J. (2007) · BioEssays · doi:10.1002/bies.20636 · Cited by 439
CD44 in Cancer Progression: Adhesion, Migration and Growth Regulation
Marhaba, R., & Zöller, M. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032354.94213.69 · Cited by 438
Expression and modulation of CD44 variant isoforms in humans
Mackay, C., Terpe, H., Stauder, R., Marston, W., Stark, H., & Günthert, U. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.1.71 · Cited by 437
Bennett, K. L., Jackson, D. G., Simon, J. C., Tanczos, E., Peach, R., Modrell, B., Stamenkovic, I., Plowman, G., & Aruffo, A. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.4.687 · Cited by 427
Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes
Tanaka, Y., Adams, D. H., & Shaw, S. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90209-4 · Cited by 400
CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma Formation, and Tumorigenicity
Schmits, R., Filmus, J., Gerwin, N., Senaldi, G., Kiefer, F., Kundig, T., Wakeham, A., Shahinian, A., Catzavelos, C., Rak, J., et al. (1997) · Blood · doi:10.1182/blood.v90.6.2217 · Cited by 391
Identification of hyaluronic acid binding sites in the extracellular domain of CD44
Peach, R., Hollenbaugh, D., Stamenkovic, I., & Aruffo, A. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.257 · Cited by 378
Leukocyte Migration and Adhesion
Imhof, B. A., & Dunon, D. (1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60623-9 · Cited by 351
Savani, R. C., Cao, G., Pooler, P. M., Zaman, A., Zhou, Z., & DeLisser, H. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102273200 · Cited by 336
Bartolazzi, A., Peach, R., Aruffo, A., & Stamenkovic, I. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.53 · Cited by 331
Cuff, C. A., Kothapalli, D., Azonobi, I., Chun, S., Zhang, Y., Belkin, R., Yeh, C., Secreto, A., Assoian, R. K., Rader, D. J., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12455 · Cited by 331
Involvement of CD44, a molecule with a thousand faces, in cancer dissemination
Naor, D., Wallach-Dayan, S. B., Zahalka, M. A., & Sionov, R. V. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.015 · Cited by 309
Fibronectin regulates calvarial osteoblast differentiation
Moursi, A. M., Damsky, C. H., Lull, J., Zimmerman, D., Doty, S. B., Aota, S.-I., & Globus, R. K. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.6.1369 · Cited by 301
Koopman, G., Heider, K. H., Horst, E., Adolf, G. R., van den Berg, F., Ponta, H., Herrlich, P., & Pals, S. T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.897 · Cited by 298
Bourguignon, L. Y. W., Zhu, H., Shao, L., & Chen, Y. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1829 · Cited by 283
Chemical Synthesis of Glycosaminoglycans
Mende, M., Bednarek, C., Wawryszyn, M., Sauter, P., Biskup, M. B., Schepers, U., & Bräse, S. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00010 · Cited by 277
A Novel Ligand for CD44 Is Serglycin, a Hematopoietic Cell Lineage-specific Proteoglycan
Toyama-Sorimachi, N., Sorimachi, H., Tobita, Y., Kitamura, F., Yagita, H., Suzuki, K., & Miyasaka, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7437 · Cited by 275
Kaya, G., Rodriguez, I., Jorcano, J. L., Vassalli, P., & Stamenkovic, I. (1997) · Genes & Development · doi:10.1101/gad.11.8.996 · Cited by 274
Understanding the Dual Nature of CD44 in Breast Cancer Progression
Louderbough, J. M. V., & Schroeder, J. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0156 · Cited by 273
Hamilton, S. R., Fard, S. F., Paiwand, F. F., Tolg, C., Veiseh, M., Wang, C., McCarthy, J. B., Bissell, M. J., Koropatnick, J., & Turley, E. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702078200 · Cited by 266
Glycosylation of CD44 negatively regulates its recognition of hyaluronan.
Katoh, S., Zheng, Z., Oritani, K., Shimozato, T., & Kincade, P. W. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.419 · Cited by 254
Osteoclasts and giant cells: macrophage–macrophage fusion mechanism
Vignery, A. (2000) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2000.00164.x · Cited by 254
Saini, K., Cho, S., Dooling, L. J., & Discher, D. E. (2020) · Matrix Biology · doi:10.1016/j.matbio.2019.06.001 · Cited by 90
Metadata
- Authors
- Jalkanen, S., & Jalkanen, M.
- Venue
- The Journal of cell biology
- Publisher
- Rockefeller University Press
- Published
- 1992-02-01
- Volume
- 116
- Issue
- 3
- Pages
- 817-825
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2141386649
- Cited by
- 530
- References
- 47
- FWCI
- 12.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.